Elevance Health Inc. (ELV) — Analyst outlook / Analyst consensus target is. Based on 37 analyst ratings, the consensus is bullish — 26 Buy, 11 Hold.
The consensus price target is $382.64 (low: $332.00, high: $425.00), representing an upside of 22.1% from the current price $313.35.
Analysts estimate Earnings Per Share (EPS) of $33.21 and revenue of $175.83B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $26.29 vs est $33.21 (missed -20.8%). 2025: actual $25.18 vs est $29.99 (missed -16%). Analyst accuracy: 77%.
ELV Stock — 12-Month Price Forecast
$382.64
▲ +22.11% Upside
Average Price Target
Based on 37 Wall Street analysts offering 12-month price targets for Elevance Health Inc., the average price target is $382.64, with a high forecast of $425.00, and a low forecast of $332.00.
The average price target represents a +22.11% change from the last price of $313.35.
Highest Price Target
$425.00
Average Price Target
$382.64
Lowest Price Target
$332.00
ELV Analyst Ratings
Buy
Based on 37 analysts giving stock ratings to Elevance Health Inc. in the past 3 months
EPS Estimates — ELV
77%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $26.29
vs Est $33.21
▼ 26.3% off
2025
Actual $25.18
vs Est $29.99
▼ 19.1% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — ELV
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $176.810B
vs Est $175.831B
▲ 0.6% off
2025
Actual $199.125B
vs Est $198.603B
▲ 0.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
